IARC research is robustly represented at the World Health Assembly

The International Agency for Research on Cancer (IARC) is represented at the Seventy-seventh World Health Assembly, which is taking place in Geneva, Switzerland, from 27 May to 1 June 2024. Several IARC scientists, including IARC Director Dr Elisabete Weiderpass, are presenting the Agency’s work during different side events to the World Health Assembly, and IARC personnel met with colleagues and other parties interested in cancer prevention at the IARC stand on Monday 27 May.

Dr Weiderpass spoke about IARC’s commitment to creating the bridge between research and practice to improve global cancer control, during a panel discussion organized by City Cancer Challenge. IARC scientists Dr Inge Huybrechts and Dr Zisis Kozlakidis provided details of the ongoing InterNatIonal CHildhood Leukemia Microbiome/MEtabolome (NICHE) study to a stakeholders meeting on nutrition and childhood noncommunicable diseases. On Friday 31 May, IARC scientists Dr Béatrice Lauby-Secretan and Dr Hilary Robbins will make presentations during a side event organized by the Union for International Cancer Control (UICC) on lung cancer; the event, titled “Protecting our lungs: Implementing strategies for lung cancer prevention, screening and care”, is about preventing lung cancer and improving effective screening and management.

Delegates to the World Health Assembly, including national ministers of health and colleagues working in other World Health Organization (WHO) programmes, came to the IARC stand to explore the cancer burden in their region on the IARC Global Cancer Observatory website, learn more about IARC’s research and programmes from the IARC personnel present, and test their knowledge of cancer risk factors through games based on the European Code Against Cancer, 4th edition.

View photos 

Visit the website of the Seventy-seventh World Health Assembly